Novel target for peptide-based imaging and treatment of brain tumors
This disconnect is not unique to BPC-157, but reflects a broader trend within the biohacking movement, where enthusiasm and anecdotal claims for emerging therapies can sometimes outpace the pace of clinical research and regulatory review
The same destination reached slowly causes less turbulence
Cell grouping and treatment This study includes seven experimental groups: (1) Control group, (2) H2O2 model group (200 M), (3) Model + AKT inhibitor group (MK-2206, 2.5 M), (4) Model + AKT activator group (SC79, 10 ng/ml), (5) Model + CGA group (500 nM), (6) Model + AKT inhibitor + CGA group, (7) Model + AKT activator + CGA group
10.1016/j.pcad.2023.04.006 77
So you benefit from all protective and detoxifying effects with the certainty of a 100% effect